Search results for "time factor"

showing 10 items of 3219 documents

Vitamin E deficiency and the susceptibility to lipid peroxidation of mouse cardiac and skeletal muscles

1984

Effects of a short-term vitamin E deficiency on some lipid peroxidative properties were investigated in mouse cardiac and skeletal muscles. The concentration of vitamin E decreased 35.8% in 5 weeks and 61.2% in 12 weeks in skeletal muscle. The corresponding decrease in cardiac muscle was 65.7% in 12 weeks. Simultaneously the susceptibility of muscle homogenates to in vitro lipid peroxidation increased with 48.6% (5 weeks) and 44.5% (12 weeks) in skeletal muscle and with 101.8% (12 weeks) in cardiac muscle. Highly significant negative correlations were observed between the concentration of vitamin E and in vitro lipid peroxidation in cardiac and skeletal muscles. Also the sensitivity to Fe2+…

MaleVitaminmedicine.medical_specialtyTime FactorsPhysiologymedicine.medical_treatmentMice Inbred StrainsBiologyLipofuscinLipid peroxidationMicechemistry.chemical_compoundInternal medicinemedicineAnimalsVitamin EVitamin E DeficiencyTocopherolchemistry.chemical_classificationMusclesMyocardiumGlutathione peroxidaseVitamin ECardiac muscleSkeletal muscleLipid Metabolismmedicine.anatomical_structureEndocrinologychemistryVitamin E deficiencyOxidation-ReductionActa Physiologica Scandinavica
researchProduct

Early motor development and later language and reading skills in children at risk of familial dyslexia.

2005

Relationships between early motor development and language and reading skills were studied in 154 children, of whom 75 had familial risk of dyslexia (37 females, 38 males; at-risk group) and 79 constituted a control group (32 females, 47 males). Motor development was assessed by a structured parental questionnaire during the child's first year of life. Vocabulary and inflectional morphology skills were used as early indicators of language skills at 3 years 6 months and 5 years or 5 years 6 months of age, and reading speed was used as a later indicator of reading skills at 7 years of age. The same subgroups as in our earlier study (in which the cluster analysis was described) were used in th…

MaleVocabularyTime Factorsmedia_common.quotation_subjectGross motor skillSeverity of Illness IndexDevelopmental psychologyDyslexiaDevelopmental NeuroscienceRisk FactorsReading (process)Surveys and QuestionnairesSeverity of illnessmedicineHumansMass ScreeningChildMotor skillmedia_commonObserver VariationLanguage DisordersDyslexiamedicine.diseaseMotor Skills DisordersLanguage developmentReadingChild PreschoolPediatrics Perinatology and Child HealthFemaleNeurology (clinical)PsychologyReading skillsDevelopmental medicine and child neurology
researchProduct

Healing in Denervated Bones

1974

MaleWound HealingTime FactorsTibiabusiness.industryAnatomyDenervationMetatarsusRatsRadiographyFractures BoneAnimalsMedicineOrthopedics and Sports MedicineSurgeryFemurBony CallusbusinessFemoral FracturesActa Orthopaedica Scandinavica
researchProduct

Anesthetic efficacy of ketamine-diazepam, ketamine-xylazine, and ketamine-acepromazine in Caspian Pond turtles (

2017

Objectives: The objective of this study was to assess the efficacy of different anesthetic drug combinations on the Caspian Pond turtles (Mauremys caspica). Subjects and Methods: Three groups of the Caspian Pond turtles (n = 6) were anesthetized with three different drug combinations. Initially, a pilot study was conducted to determine the best drug doses for the anesthetization of the turtles, and according to these results, ketamine–diazepam (120 mg/kg ketamine hydrochloride [5%] and 2 mg/kg diazepam [5%]), ketamine–acepromazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg acepromazine [1%]), and ketamine–xylazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg xylazine [2%]) wer…

MaleXylazineDiazepamTime FactorsDose-Response Relationship DrugketamineShort CommunicationPilot ProjectsInjections IntramuscularTurtlesSex FactorsAnesthesia Recovery PeriodAnimalsFemaleAcepromazineAnestheticsMauremys caspicaIndian journal of pharmacology
researchProduct

Anesthetic efficacy of ketamine-diazepam, ketamine-xylazine, and ketamine-acepromazine in Caspian Pond turtles (Mauremys caspica)

2017

Objectives: The objective of this study was to assess the efficacy of different anesthetic drug combinations on the Caspian Pond turtles (Mauremys caspica). Subjects and Methods: Three groups of the Caspian Pond turtles (n = 6) were anesthetized with three different drug combinations. Initially, a pilot study was conducted to determine the best drug doses for the anesthetization of the turtles, and according to these results, ketamine-diazepam (120 mg/kg ketamine hydrochloride [5%] and 2 mg/kg diazepam [5%]), ketamine-acepromazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg acepromazine [1%]), and ketamine-xylazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg xylazine [2%]) wer…

MaleXylazinePharmacologyDiazepamketamineDose-Response Relationship DrugTime FactorAnimalAnestheticSex FactorInjections IntramuscularTurtleAnesthesia Recovery PeriodFemalePilot ProjectPharmacology (medical)Mauremys caspicaAcepromazine
researchProduct

Utility of lateral flow tests in SARS-CoV-2 infection monitorization

2020

Introduction. The diagnosis of SARS-CoV-2 infection is crucial for medical and public health reasons, to allow the best treatment of cases and the best control of the pandemic. Serology testing allows for the detection of asymptomatic infections and 19-COVID cases once the virus has been cleared. We analyzed the usefulness of the SARS-CoV-2 rapid test of Autobio and tried to correlate its pattern with the severity of COVID19 infection. Material and methods. We analyzed the accuracy and clinical usefulness of a point-of-care IgM and/or IgG test for SARS-CoV-2 in 35 COVID-19 patients [12 (34.3%) mild-moderate and 23 (65.7%) severe-critical] admitted to a field hospital in Madrid, as well as i…

Malebandas débilmente positivas0301 basic medicineTime FactorsOriginalCross-sectional studyinfección por COVID-19weak positive bandsDiseaseAntibodies ViralSeverity of Illness IndexSerologyCOVID-19 Testing0302 clinical medicineSerologic rapid tests030212 general & internal medicineAsymptomatic InfectionsImmunoassaybiologyReverse Transcriptase Polymerase Chain ReactionGeneral MedicineMiddle AgedPoint-of-Care TestingFemaleSymptom Assessmentmedicine.symptomAntibodyCoronavirus InfectionsAdultMicrobiology (medical)medicine.medical_specialtyPoint-of-care testingPneumonia ViralSensitivity and SpecificityAsymptomaticVirusBetacoronavirus03 medical and health sciencesInternal medicineSeverity of illnessmedicineHumanstest serológicos rápidosPandemicsAgedPharmacologyClinical Laboratory TechniquesSARS-CoV-2business.industryCOVID-19COVID-19 infectionCross-Sectional Studies030104 developmental biologyImmunoglobulin MAutobioImmunoglobulin Gbiology.proteinbusinessRevista Española de Quimioterapia
researchProduct

Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study

2017

Objectives: Osteonecrosis of the jaw (ONJ) is a potentially severe adverse effect of bisphosphonates (BP). Although the risk of ONJ increases with increasing duration of BP treatment, there are currently no reliable estimates of the ONJ time to onset (TTO). The objective of this study was to estimate the TTO and associated risk factors in BP-treated patients. Subjects and Methods: Retrospective analysis of data from 22 secondary care centres in seven countries relevant to 349 patients who developed BP-related ONJ between 2004 and 2012. Results: The median (95%CI) TTO was 6.0 years in patients treated with alendronate (n = 88) and 2.2 years in those treated with zoledronate (n = 218). Multiv…

MalebisphosphonateTime Factorsmedicine.medical_treatmentOsteoporosis0302 clinical medicineRisk Factors80 and overosteoporosijaw osteonecrosiAged 80 and overBone Density Conservation AgentsDiphosphonatesjaw osteonecrosisjaw osteonecrosis bisphosphonates breast cancer multiple myeloma prostate cance osteoporosisIncidenceIncidence (epidemiology)Otorhinolaryngology2734 Pathology and Forensic MedicineMiddle Agedprostate cancermultiple myeloma030220 oncology & carcinogenesisBisphosphonate-Associated Osteonecrosis of the JawFemaleAdultmedicine.medical_specialty2734Drug Administration SchedulePathology and Forensic Medicine03 medical and health sciencesbreast cancerbisphosphonates; breast cancer; jaw osteonecrosis; multiple myeloma; osteoporosis; prostate cancer; Adult; Aged; Aged 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cross-Sectional Studies; Diphosphonates; Drug Administration Schedule; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Otorhinolaryngology; 2734; Pathology and Forensic Medicine; Dentistry (all)Internal medicinemedicineHumansBisphosphonates; Breast cancer; Jaw osteonecrosis; Multiple myeloma; Osteoporosis; Prostate cancer; Otorhinolaryngology2734 Pathology and Forensic Medicine; Dentistry (all)prostate canceAdverse effectGeneral DentistrybisphosphonatesAgedProportional Hazards ModelsRetrospective StudiesBisphosphonate-associated osteonecrosis of the jawbusiness.industryProportional hazards modelRetrospective cohort study030206 dentistryBisphosphonatemedicine.diseaseosteoporosisSurgeryCross-Sectional StudiesOtorhinolaryngologyMultivariate AnalysisDentistry (all)businessOsteonecrosis of the jaw
researchProduct

Long-term outcome of dental implants after maxillary augmentation with and without bone grafting

2016

Background: This study aims to evaluate the technique of sinus bone reformation, which consists of elevating the sinus membrane and placement the implant without bone graft, compared with the widely-used technique involving raising the maxillary sinus and grafting, using animal hydroxyapatite as the filler, while simultaneously fixing the implants. Material and Methods: This is a retrospective study on two groups of patients who underwent elevation of the sinus membrane and simultaneous placement of the implant. The grafting technique was applied to one group, while the other had no graft. An alveolar ridge height of 4 to 7 mm was necessary. Radiological control was undertaken at 6 months a…

Malebone graftingImmediateLiftTime FactorsSurvivalMaxillary sinusmedicine.medical_treatmentIntegrationSinus liftDentistryBone graftingPosterior maxillasinus membrane elevation0302 clinical medicineMedicineBone TransplantationImplant failureAlveolar Ridge AugmentationAlveolar Ridge AugmentationMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Clinical reportCiencias de la saludmedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesisBone formationUNESCO::CIENCIAS MÉDICASFemalemaxillary sinusOral SurgeryAdultOdontologíaOsseointegration03 medical and health sciencesFloor augmentationAlveolar ridgeHumansGeneral DentistryPlacementAgedRetrospective StudiesDental Implantsbusiness.industryResearchBovine bone030206 dentistryOtorhinolaryngologySurgeryImplantbusiness
researchProduct

Mercury exposure and risk of cardiovascular disease: a nested case-control study in the PREDIMED (PREvention with MEDiterranean Diet) study

2017

Background: Substantial evidence suggests that consuming 1-2 servings of fish per week, particularly oily fish (e.g., salmon, herring, sardines) is beneficial for cardiovascular health due to its high n-3 polyunsaturated fatty acid content. However, there is some concern that the mercury content in fish may increase cardiovascular disease risk, but this relationship remains unclear. Methods: The PREDIMED trial included 7477 participants who were at high risk for cardiovascular disease at baseline. In this study, we evaluated associations between mercury exposure, fish consumption and cardiovascular disease. We randomly selected 147 of the 288 cases diagnosed with cardiovascular disease duri…

Malecompuestos de metilmercurioTime Factorsmodelos logísticosMediterranean diethumanos030204 cardiovascular system & hematologyDiet MediterraneanRecommended Dietary AllowancesDieta mediterrània1471-22610302 clinical medicineRisk Factorsestudios prospectivosevaluación de riesgosOdds RatioOily fishWater Pollutants030212 general & internal medicineProspective StudiesToenail biomarkeruñasmediana edadCiències de la salutAged 80 and overeducation.field_of_studyBioquímica y tecnologíaanciano:Ciencias de la Salud::Salud pública [Materias Investigacion]dietaMALALTIES CARDIOVASCULARSMethylmercury CompoundsMiddle Agedcontaminantes del aguaCardiovascular diseaseCiencias de la saludcociente de probabilidades relativasBiochemistry and technologyCardiovascular DiseasesBody BurdenFemaleCardiology and Cardiovascular Medicinecantidad dietética recomendadaResearch ArticlePREDIMEDmedicine.medical_specialtyPopulationestudios de casos y controlesenfermedades cardiovasculareschemistry.chemical_elementFood ContaminationSistema cardiovascular malaltiesBioquímica i biotecnologiaRisk Assessment03 medical and health sciencesalimentos del marfactores de tiempoEnvironmental healthMediterranean dietmedicineHumansfactores de riesgoMercuri -- Toxicologiaanálisis multifactorialeducationCardivascular diseaseAgedbusiness.industryCase-control studyHealth sciencesOdds ratioMercuryProtective FactorsSurgeryMercury (element)DietLogistic ModelsFishchemistrySeafoodNailsSpainRelative riskCase-Control StudiesNested case-control studyMultivariate AnalysisbusinessWater Pollutants Chemicalcarga corporal
researchProduct

The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with …

2006

Hyperhomocysteinemia is considered an independent risk factor for atherosclerosis, atherothrombosis and Venous ThromboEmbolism (VTE) [1], [2] and [3]. Normal total plasma homocysteine concentrations range from 5 to 15 μmol/L in the fasting state. Hyperhomocysteinemia is classified as moderate (homocysteine concentration, 15 to 30 μmol/L), intermediate (> 30 to 100 μmol/L), and severe (> 100 μmol/L) on the basis of concentrations measured during fasting. Although severe hyperhomocysteinemia is rare, mild hyperhomocysteinemia occurs in approximately 5% to 7% of the general population. In this case, patients are typically asymptomatic until the third or fourth decade of life when premature Cor…

Malecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyHyperhomocysteinemiaTime FactorsHomocysteinePopulationHyperhomocysteinemiaGastroenterologyAsymptomaticchemistry.chemical_compoundFolic AcidRecurrenceRisk FactorsInternal medicineMedicineHumansIn patientRisk factoreducationHomocysteineAgededucation.field_of_studybusiness.industrynutritional and metabolic diseasesHematologyMiddle Agedmedicine.diseaseB vitaminsEndocrinologyTreatment OutcomechemistryCardiovascular DiseasesVitamin B ComplexPlasma homocysteineFemalemedicine.symptombusinessThrombosis research
researchProduct